Sodium Salicylate is the sodium salt of salicylic acid. As a nonsteroidal anti-inflammatory drug (NSAID), sodium salicylate irreversibly acetylates cyclooxygenases I and II, thereby inhibiting prostaglandin synthesis and associated inflammation and pain. This agent may also activate mitogen-activated protein kinase (p38MAPK), thereby inducing apoptosis in cancer cells. It is grouped under the following drug class(es): Keratolytics and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as antipyretics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Enterosalicyl, Kerasalicyl and Alysine. It is also listed for alternate use as: API Intermediate. Its PubChem CID is 16760658.
Sodium salicylate
| CAS No | 54-21-7 |
|---|---|
| Molecular Formula | C7H5NaO3 |
| Molecular Weight | 160.10 g/mol |
| Synonyms | sodium;2-hydroxybenzoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Sodium Salicylate is the sodium salt of salicylic acid. As a nonsteroidal anti-inflammatory drug (NSAID), sodium salicylate irreversibly acetylates cyclooxygenases I and II, thereby inhibiting prostaglandin synthesis and associated inflammation and pain.
The listed CAS number is 54-21-7.
The listed molecular formula is C7H5NaO3.
The listed molecular weight is 160.10 g/mol.
sodium;2-hydroxybenzoate.
The source lists Enterosalicyl, Kerasalicyl and Alysine.